IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 83 filers reported holding IMMUNOMEDICS INC in Q3 2013. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $21,836,000 | +145.1% | 256,808 | +2.1% | 0.05% | +127.3% |
Q2 2020 | $8,910,000 | +693.4% | 251,418 | +201.7% | 0.02% | +633.3% |
Q1 2020 | $1,123,000 | -36.3% | 83,334 | 0.0% | 0.00% | -25.0% |
Q4 2019 | $1,763,000 | +59.5% | 83,334 | 0.0% | 0.00% | +33.3% |
Q3 2019 | $1,105,000 | -4.4% | 83,334 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $1,156,000 | -24.1% | 83,334 | +5.1% | 0.00% | -25.0% |
Q1 2019 | $1,523,000 | +34.7% | 79,284 | 0.0% | 0.00% | +33.3% |
Q4 2018 | $1,131,000 | -31.5% | 79,284 | 0.0% | 0.00% | -25.0% |
Q3 2018 | $1,651,000 | -12.0% | 79,284 | 0.0% | 0.00% | -20.0% |
Q2 2018 | $1,877,000 | +61.9% | 79,284 | -0.1% | 0.01% | +66.7% |
Q1 2018 | $1,159,000 | -11.5% | 79,324 | -2.2% | 0.00% | 0.0% |
Q4 2017 | $1,310,000 | +15.6% | 81,067 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $1,133,000 | +37.8% | 81,067 | -12.9% | 0.00% | +50.0% |
Q2 2017 | $822,000 | +36.5% | 93,107 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $602,000 | +76.0% | 93,107 | 0.0% | 0.00% | +100.0% |
Q4 2016 | $342,000 | +12.9% | 93,107 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $303,000 | +40.3% | 93,107 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $216,000 | -7.3% | 93,107 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $233,000 | -18.5% | 93,107 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $286,000 | +78.8% | 93,107 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $160,000 | -57.7% | 93,107 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $378,000 | +5.9% | 93,107 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $357,000 | -27.7% | 93,107 | -9.5% | 0.00% | -50.0% |
Q4 2014 | $494,000 | +29.0% | 102,845 | 0.0% | 0.00% | +100.0% |
Q3 2014 | $383,000 | +2.1% | 102,845 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $375,000 | -13.4% | 102,845 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $433,000 | -8.5% | 102,845 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $473,000 | -25.7% | 102,845 | 0.0% | 0.00% | -50.0% |
Q3 2013 | $637,000 | +14.0% | 102,845 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $559,000 | – | 102,845 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |